Daiichi Sankyo/Forest's Hypertension Therapy Azor Gets FDA Nod
This article was originally published in PharmAsia News
Executive Summary
Other combination products containing amlodipine include Novartis' Lotrel (amlodipine/benazepril) and Exforge (amlodipine/valsartan); the latter was just approved in June ("The Pink Sheet" DAILY, June 21, 2007).
You may also be interested in...
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required.)
Need a specific report? 1000+ reports available
Buy Reports